Fenofibrate is a medication used to manage high cholesterol and triglyceride levels in the blood [1]. It belongs to a class of drugs known as fibrates [2].
How does fenofibrate work to lower cholesterol?
Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs) in the liver and other tissues [3]. This activation leads to a decrease in the production of triglycerides and LDL cholesterol (often referred to as "bad" cholesterol) while increasing HDL cholesterol (often referred to as "good" cholesterol) [3][4].
What conditions does fenofibrate treat?
Fenofibrate is primarily prescribed to treat hypertriglyceridemia (high levels of triglycerides) and mixed dyslipidemia (high levels of both triglycerides and cholesterol) [1][4]. It can also be used in patients with diabetes to reduce the risk of cardiovascular events, such as heart attack and stroke, in those who have established cardiovascular disease or multiple cardiovascular risk factors [5].
What are the different types of fenofibrate medications available?
Fenofibrate is available in various formulations, including immediate-release and delayed-release capsules, as well as micronized and nanoparticle formulations that can affect absorption and dosing [6]. Brand names include Tricor and Antara, among others [6].
When do fenofibrate patents expire?
Patent expiries for fenofibrate are complex due to multiple patents covering different aspects of the drug, including its formulation and method of use. Information on specific patent expiry dates can be found on resources like DrugPatentWatch.com [7]. For instance, patents related to certain formulations or indications may have expired or will expire at different times.
Who are the main manufacturers and competitors of fenofibrate?
Abbott Laboratories (now AbbVie) originally developed Tricor. The market for fenofibrate includes both branded and generic versions. Several pharmaceutical companies manufacture generic fenofibrate, increasing competition and potentially lowering prices [8]. Competitors in the broader dyslipidemia market include other classes of drugs like statins and ezetimibe.
What is the typical cost of fenofibrate?
The cost of fenofibrate can vary significantly depending on whether a patient is using a brand-name or generic version, their insurance coverage, and the specific dosage and formulation prescribed [9]. Generic options are generally more affordable.
What are the potential side effects of fenofibrate?
Common side effects of fenofibrate can include gastrointestinal issues like nausea, vomiting, and diarrhea, as well as headache, dizziness, and muscle pain [1][10]. More serious side effects, though less common, can include liver problems, pancreatitis, and muscle damage (rhabdomyolysis) [1][10]. It is important for patients to discuss any concerns with their healthcare provider.
Are there alternatives to fenofibrate for managing cholesterol?
Yes, several alternative treatments exist for managing high cholesterol and triglyceride levels. These include statins, which are often the first-line treatment for high LDL cholesterol, as well as bile acid sequestrants, niacin, and PCSK9 inhibitors [11]. The choice of treatment depends on the specific lipid profile, patient health status, and other risk factors.
What are the risks associated with taking fenofibrate?
Potential risks include adverse effects on the liver and pancreas, and an increased risk of muscle problems, especially when taken with statins [1][10]. Fenofibrate can also interact with other medications, so it is crucial for patients to inform their doctor about all drugs they are taking [1].
What clinical data supports the use of fenofibrate?
Clinical trials have demonstrated fenofibrate's efficacy in lowering triglyceride levels and its benefit in reducing cardiovascular events in certain patient populations, particularly those with diabetes and dyslipidemia [5]. Studies like the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) lipid trial have provided significant data on its use [5].
Sources:
[1] https://medlineplus.gov/druginfo/meds/a607017.html
[2] https://www.rxlist.com/script/main/art.asp?articlekey=162469
[3] https://pubmed.ncbi.nlm.nih.gov/12535448/
[4] https://www.mayoclinic.org/drugs-supplements/fenofibrate-oral-capsule-oral-tablet/proper-use/drg-20063003
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa0805721
[6] https://www.drugbank.ca/drugs/DB00669
[7] https://www.drugpatentwatch.com/
[8] https://www.ncbi.nlm.nih.gov/books/NBK555942/
[9] https://www.goodrx.com/fenofibrate
[10] https://www.webmd.com/drugs/2/drug-16058/fenofibrate-oral/details
[11] https://www.heart.org/en/health-topics/cholesterol/treatment-and-prevention/cholesterol-medications